企业摘要
季度业绩走势
营业收入
营业利润率
市场偏好度
※ 点击图表可查看该月份的AI分析信息。
营业收入
合并
单独
营业利润
合并
单独
净利润
合并
单独
财务信息
保存为Excel
该期间没有财务信息数据。
~
季度
决算
*单位基准小数点第四位以下的数值标记为'0/-0'
财务指标预测
※ 本预测值是基于历史数据的AI简单估算值，可能与实际业绩存在差异。
企业概况
截至2026年6月
CKD Bio Corp. was spun off and newly established from CKD Pharmaceutical Corporation's active pharmaceutical ingredient business division in November 2001, and operates an advanced integrated fermentation facility on a 51,473.2 square meter site in Ansan, exporting more than 30 types of active pharmaceutical ingredients and finished products worldwide, including to the United States, Southeast Asia, China, Latin America, the Middle East, Europe, and Africa. The company's main production items include active pharmaceutical ingredients such as Potassium Clavulanate, DMCT, Rifamycin O, and Acarbose, used in antibiotics, diabetes treatments, irritable bowel syndrome treatments, and immunosuppressants, and it has recently been putting great effort into the research and development of high-value-added new products targeting developed country markets.
代表理事
Park Wangap
成立日期
2001年11月12日
法人类型
韩国综合股价指数
行业分类
Manufacture of medicaments
法人注册号
11011-2373308
营业执照号
110-81-53652
电话号码
02-2194-0555
传真号码
02-2194-0556
公司地址
8 Chungjeong-ro, Seodaemun-gu, Seoul
产品与服务
评论